D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 86,900
-2,700 (-3.01%)
Jun 10, 2026, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 3.92 trillion as of June 10, 2026. Its market cap has increased by 308.65% in one year.
Market Cap
3.92T
Enterprise Value
3.91T
Revenue
3.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
86,900.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 3.92T, an increase of 934.05%. That is a compound annual growth rate of 203.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 3.92T | -1.79% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kolon TissueGene | 7.57T |
| SK Biopharmaceuticals | 6.45T |
| HLB Co., Ltd. | 6.42T |
| Peptron | 5.37T |
| LigaChem Biosciences | 4.29T |
| Voronoi | 3.26T |
| SK bioscience | 2.93T |
| PharmaResearch | 2.69T |